WELLS FARGO & COMPANY/MN - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 48 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$4,638
-33.7%
12,5000.0%0.00%
Q3 2022$7,000
-12.5%
12,5000.0%0.00%
Q2 2022$8,000
-11.1%
12,5000.0%0.00%
Q1 2022$9,000
+800.0%
12,500
+1150.0%
0.00%
Q4 2021$1,000
-66.7%
1,000
-20.6%
0.00%
Q3 2021$3,000
-57.1%
1,259
-24.7%
0.00%
Q2 2021$7,000
-41.7%
1,6730.0%0.00%
Q1 2021$12,000
+71.4%
1,673
-4.9%
0.00%
Q4 2020$7,0000.0%1,7590.0%0.00%
Q3 2020$7,000
+75.0%
1,759
+151.3%
0.00%
Q2 2020$4,000
-20.0%
7000.0%0.00%
Q1 2020$5,0000.0%700
+79.5%
0.00%
Q4 2019$5,0003900.00%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders